PGI3 RISK OF UPPER GASTROINTESTINAL ADVERSE EVENTS AND THE EFFECT OF ACID-SUPPRESSIVE THERAPY IN PATIENTS RECEIVING ACETYLSALICYLIC ACID FOR CARDIOVASCULAR RISK MANAGEMENT
Abstract
Authors
S Johansson B Farahmand S Joelson L Estborn MA Wallander